Findings

What do systematic reviews say?

16 questions · 16 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 16 · 100%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Third generation cephalosporins vs conventional therapy

Death · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
19 studies · 1496 participants
GRADE not reported

Third generation cephalosporins vs conventional therapy

Death · patients treated for meningococcal meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
13 studies · 477 participants
GRADE not reported

Third generation cephalosporins vs conventional antibiotics (high and low/middle‐income countries)

Death · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
19 studies · 1301 participants
GRADE not reported

Third generation cephalosporins vs conventional antibiotics (high and low/middle‐income countries)

Death: high‐income countries · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 510 participants
GRADE not reported

Third generation cephalosporins vs conventional antibiotics (high and low/middle‐income countries)

Death: Low/middle‐income countries · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 791 participants
GRADE not reported

Third generation cephalosporins vs conventional antibiotics (high and low/middle‐income countries)

Deafness · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 501 participants
GRADE not reported

Third generation cephalosporins vs conventional antibiotics (high and low/middle‐income countries)

Deafness: high‐income countries · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 380 participants
GRADE not reported

Third generation cephalosporins vs conventional antibiotics (high and low/middle‐income countries)

Deafness: low‐income countries · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 121 participants
GRADE not reported

Third generation cephalosporins vs conventional therapy

Deafness · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 501 participants
GRADE not reported

Third generation cephalosporins vs conventional therapy

Culture positivity 10 to 48 hours start of treatment · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 442 participants
GRADE not reported

Third generation cephalosporins vs conventional therapy

Diarrhoea · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 750 participants
GRADE not reported

Third generation cephalosporins vs conventional therapy

Neutropenia · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 472 participants
GRADE not reported

Third generation cephalosporins vs conventional therapy

Rash · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 533 participants
GRADE not reported

Third generation cephalosporins vs conventional therapy

Treatment failure (either death or deafness) · patients treated for acute bacterial meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
19 studies · 1496 participants
GRADE not reported

Third generation cephalosporins vs conventional antibiotics (high and low/middle‐income countries)

Death · patients treated for S. pneumoniae meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 129 participants
GRADE not reported

Cephalosporins vs conventional therapy

Death · patients treated for H. influenzae meningitis

1 finding from 1 review

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis 2007 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 318 participants
GRADE not reported